- Home
- IMNM vs CNOBP Comparison
IMNM vs CNOBP Comparison
Compare IMNM & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- CNOBP
- Stock Information
- Founded
- IMNM 2006
- CNOBP N/A
- Country
- IMNM United States
- CNOBP United States
- Employees
- IMNM N/A
- CNOBP 499
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- CNOBP Major Banks
- Sector
- IMNM Health Care
- CNOBP Finance
- Exchange
- IMNM Nasdaq
- CNOBP Nasdaq
- Market Cap
- IMNM 747.7M
- CNOBP N/A
- IPO Year
- IMNM 2020
- CNOBP N/A
- Fundamental
- Price
- IMNM $12.30
- CNOBP $21.35
- Analyst Decision
- IMNM Strong Buy
- CNOBP
- Analyst Count
- IMNM 4
- CNOBP 0
- Target Price
- IMNM $28.75
- CNOBP N/A
- AVG Volume (30 Days)
- IMNM 859.8K
- CNOBP N/A
- Earning Date
- IMNM 11-07-2024
- CNOBP N/A
- Dividend Yield
- IMNM N/A
- CNOBP N/A
- EPS Growth
- IMNM N/A
- CNOBP N/A
- EPS
- IMNM N/A
- CNOBP N/A
- Revenue
- IMNM $10,784,000.00
- CNOBP N/A
- Revenue This Year
- IMNM N/A
- CNOBP N/A
- Revenue Next Year
- IMNM N/A
- CNOBP N/A
- P/E Ratio
- IMNM N/A
- CNOBP N/A
- Revenue Growth
- IMNM 62.73
- CNOBP N/A
- 52 Week Low
- IMNM $6.93
- CNOBP N/A
- 52 Week High
- IMNM $30.96
- CNOBP N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 35.27
- CNOBP 60.36
- Support Level
- IMNM $12.24
- CNOBP $20.95
- Resistance Level
- IMNM $13.40
- CNOBP $21.50
- Average True Range (ATR)
- IMNM 0.84
- CNOBP 0.32
- MACD
- IMNM -0.25
- CNOBP 0.00
- Stochastic Oscillator
- IMNM 10.58
- CNOBP 60.92
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a holding company. The company through its holding provides banking services including lending, depository, and related financial services to commercial, industrial and governmental customers. It is managed as one segment: a community bank. It generates revenue from net interest income.